Delayed hemolytic transfusion reaction in sickle cell disease patients: Evidence of an emerging syndrome with suicidal red blood cell death

Transfusion

Volumn 49, Issue 9, 2009, Pages 1785-1792

  Chadebech, Philippe ^a   Habibi, Anoosha ^a   Nzouakou, Ruben ^a   Bachir, Dora ^a   Meunier Costes, Natacha ^a   Bonin, Philippe ^a   Rodet, Martine ^a   Chami, Btissam ^a   Galacteros, Frederic ^a   Bierling, Philippe ^a   Noizat Pirenne, France ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PHOSPHATIDYLSERINE;

ADULT; ANTIBODY DETECTION; APOPTOSIS; ARTICLE; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; BLOOD VESSEL OCCLUSION; CELL DEATH; CELL SURFACE; CELL SURVIVAL; CLINICAL ARTICLE; DELAYED HEMOLYTIC TRANSFUSION REACTION; ERYPTOSIS; ERYTHROCYTE LIFESPAN; HEMOLYSIS; HUMAN; MACROPHAGE ACTIVATION; SICKLE CELL ANEMIA; SYNDROME;

ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CELL DEATH; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HEMOLYSIS; HUMANS; MALE; PHOSPHATIDYLSERINES; SYNDROME; YOUNG ADULT;

EID: 69249169929     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02199.x     Document Type: Article

References (22)

1. Win N, New H, Lee E, de la Fuente J. Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion 2008 48 : 1231 8.
2. Zimring JC, Spitalnik SL, Roback JD, Hillyer CD. Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens: a novel hypothesis. Transfusion 2007 47 : 2189 96.
3. Noizat-Pirenne F, Bachir D, Chadebech P, Michel M, Plonquet A, Lecron JC, Galacteros F, Bierling P. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica 2007 92 : e132 5.
4. Petz LD. Bystander immune cytolysis. Transfus Med Rev 2006 20 : 110 40.
5. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005 293 : 1653 62.
6. Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001 41 : 323 8.
7. Garratty G. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction? Transfus Med 2008 18 : 321 34.
8. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F. Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005 15 : 195 202.
9. Lang F, Lang KS, Lang PA, Huber SM, Wieder T. Mechanisms and significance of eryptosis. Antioxid Redox Signal 2006 8 : 1183 92.
10. de Jong K, Kuypers FA. Sulphydryl modifications alter scramblase activity in murine sickle cell disease. Br J Haematol 2006 133 : 427 32.
11. Yasin Z, Witting S, Palascak MB, Joiner CH, Rucknagel DL, Franco RS. Phosphatidylserine externalization in sickle red blood cells: associations with cell age, density, and hemoglobin F. Blood 2003 102 : 365 70.
12. Hod EA, Sokol SA, Zimring JC, Spitalnik SL. Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxis. Int J Clin Exp Pathol 2009 2 : 71 82.
13. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996 88 : 1873 80.
14. Dumaswala UJ, Wilson MJ, Wu YL, Wykle J, Zhuo L, Douglass LM, Daleke DL. Glutathione loading prevents free radical injury in red blood cells after storage. Free Radic Res 2000 33 : 517 29.
15. Bennett-Guerrero E, Veldman TH, Doctor A, Telen MJ, Ortel TL, Reid TS, Mulherin MA, Zhu H, Buck RD, Califf RM, McMahon TJ. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A 2007 104 : 17063 8.
16. Nicolay JP, Liebig G, Niemoeller OM, Koka S, Ghashghaeinia M, Wieder T, Haendeler J, Busse R, Lang F. Inhibition of suicidal erythrocyte death by nitric oxide. Pflugers Arch 2008 456 : 293 305.
17. Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006 46 : 105 10.
18. Terpstra V, van Berkel TJ. Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 2000 95 : 2157 63.
19. Liu C, Marshall P, Schreibman I, Vu A, Gai W, Whitlow M. Interaction between terminal complement proteins C5b-7 and anionic phospholipids. Blood 1999 93 : 2297 301.
20. Neidlinger NA, Larkin SK, Bhagat A, Victorino GP, Kuypers FA. Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem 2006 281 : 775 81.
21. Kau DK, Finnegan E, Barabino GA. Sickle red cell-endothelium interactions. Microcirculation 2009 16 : 97 111.
22. Kuypers FA. Membrane lipid alterations in hemoglobinopathies. Hematology Am Soc Hematol Educ Program 2007 2007 : 68 73.